Progyny partners with ŌURA to bring wearable health insights into reproductive care — from preconception to menopause
Progyny has become the latest women’s health company to partner with ŌURA, maker of the popular smart ring, bringing wearable data directly into its reproductive health care.
The partnership will integrate ŌURA’s biometric insights — spanning everything from sleep and cardiovascular signals to stress levels and menstrual patterns — into Progyny’s wraparound clinical care model. The move is designed to support care teams and patients alike with a clearer, day-to-day picture of how their bodies are changing and responding.
ŌURA’s wearable will be available to Progyny clients, including employers and health plans, beginning in early 2026. Progyny says that as a result of the integration, potential risks can be identified earlier, while also supporting a range of health goals, such as optimizing conception attempts or making sustainable lifestyle changes.
“The more women understand about their bodies, the more empowered they are to partner with their health providers and articulate their health status and goals,” said Dr Janet Choi, Progyny’s Chief Medical Officer.
“Whether you are focused on conceiving your first child or managing changing weight and sleep issues through menopause, understanding your personal data is powerful—physically and emotionally. Taking control with physiologic data from the Oura Ring further supports Progyny’s focus on raising the bar and elevating health outcomes.”
Wearables meet whole-person care
The integration aims to give Progyny care teams earlier signals into potential issues—and help members connect the dots between their everyday symptoms and the bigger picture. ŌURA’s smart ring captures trends in sleep, temperature, heart rate variability, cycle fluctuations, and more. These insights can be especially valuable during periods of hormonal change, like trying to conceive or transitioning through menopause, when symptoms are often diffuse, missed, or misunderstood.
Progyny’s offering includes personalised coaching, digital tools, and a network of specialists spanning fertility, women’s health, and hormone care. With the addition of biometric data, the company says it can now go even further in supporting patients to proactively manage cycles, adjust lifestyle routines, and better understand physiological shifts.
For people trying to conceive, for example, the smart ring may help pinpoint fertile windows and optimise timing for treatment or conception attempts. During perimenopause, it could help spot sleep disruptions or cardiovascular changes early—offering a clearer basis for lifestyle changes or medical input.
“Reproductive health management starts long before a doctor's visit—it begins with daily awareness of your body's patterns,” said Dorothy Kilroy, Chief Commercial Officer at ŌURA.
“By partnering with Progyny, we’re bridging the gap between those daily health patterns and clinical care, helping people navigate fertility and family planning with greater clarity, confidence, and support. This collaboration brings Oura’s powerful health signals into a setting where they can truly make a difference—guiding smarter care, earlier interventions, and more personalized journeys.”
The second ŌURA partnership in women’s health in the last month
This marks the second major women’s health integration for ŌURA in the last four weeks. In late June, Maven Clinic announced a similar partnership — signalling a shift toward more integrated, longitudinal care models where patient-generated data informs real-time decision-making.
With rising demand for personalised care and greater digital engagement from women tracking their own cycles, sleep, and stress, platforms like Progyny are tapping into wearable tech to fill long-standing gaps in reproductive and hormonal care.
ŌURA currently counts more than 1 million users worldwide, and its ring has become particularly popular among women using it for cycle tracking (with integrations into Natural Cycles and Clue among others), sleep support, and performance recovery.
With this latest partnership, the company is cementing its role not just as a consumer product, but as a clinical data source that could help shape care plans and drive more proactive support across the reproductive lifespan.